We are live on ! Find out more
BPTH

Bio-Path Holdings Inc
BPTH

Delisted

BPTH was delisted on the 18th of February, 2025.

Back to rankings

21 hedge funds and large institutions have $793K invested in Bio-Path Holdings Inc in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 3

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

5% more funds holding

Funds holding: 20 → 21 (+1)

17% less capital invested

Capital invested by funds: $955K → $793K (-$162K)

Holders
21
Holders Change
+1
Holders Change %
+5%
% of All Funds
0.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
5
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$31.3K
2
Citadel Advisors
Citadel Advisors
Florida
+$28.2K
3
Bank of America
Bank of America
North Carolina
+$5.58K
4
Group One Trading
Group One Trading
Illinois
+$3.6K
5
Renaissance Technologies
Renaissance Technologies
New York
+$1.98K

Top Sellers

Rank Fund Capital Flow
1
Walleye Capital
Walleye Capital
New York
-$201K
2
UBS Group
UBS Group
Switzerland
-$4.64K
3
TRCT
Tower Research Capital (TRC)
New York
-$2.05K
4
MCC
Money Concepts Capital
Florida
-$453

BPTH Hedge Fund Activity: Q1 2023 in Review

21 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Bio-Path Holdings Inc (BPTH) for Q1 2023, worth a combined $793K — down 17% from $955K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new BPTH positions and 2 closed out — a net gain of 1 holder — while 5 added to existing stakes and 3 trimmed.

The largest buyer was Vanguard Group, adding an estimated $31.3K. The largest seller was Walleye Capital, cutting an estimated $201K.

  • 21 institutional investors held Bio-Path Holdings Inc (BPTH) as of Q1 2023, up from 20 in Q4 2022.
  • Funds reported $793K of Bio-Path Holdings Inc stock for Q1 2023, down 17% quarter-over-quarter.
  • 3 funds opened new Bio-Path Holdings Inc positions in Q1 2023 and 2 closed out, a net change of +1 holder.
  • The largest Bio-Path Holdings Inc buyer in Q1 2023 was Vanguard Group, an estimated $31.3K added.
  • The largest Bio-Path Holdings Inc seller in Q1 2023 was Walleye Capital, an estimated $201K sold.

Based on aggregated 13F filings for Q1 2023.